Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication July 20, 2006
- Accepted for publication October 12, 2006
- Published online January 4, 2007.
Copyright & Usage
© 2007 by Society of Nuclear Medicine
Author Information
- David M. Schuster 1 ,
- John R. Votaw 1 ,
- Peter T. Nieh 2 ,
- Weiping Yu 1 ,
- Jonathon A. Nye 1 ,
- Viraj Master 2 ,
- F. DuBois Bowman 3 ,
- Muta M. Issa 2 and
- Mark M. Goodman 1
- 1Division of Nuclear Medicine, Department of Radiology, Emory University, Atlanta, Georgia; 2Department of Urology, Emory University, Atlanta, Georgia; and 3Department of Biostatistics, Emory University, Atlanta, Georgia
- For correspondence or reprints contact: David M. Schuster, MD, Department of Radiology, Emory University Hospital, Room E145, 1364 Clifton Rd., Atlanta, GA 30322. E-mail: david.schuster{at}emoryhealthcare.org
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
- Characterizing and Mitigating Bladder Radioactivity on 18F-Fluciclovine PET/CT
- 18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer
- Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
- Molecular Imaging of Prostate Cancer: Choosing the Right Agent
- Impact of 18F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial
- Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs
- Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naive and Castration-Resistant Metastatic Prostate Cancer
- Boramino acid as a marker for amino acid transporters
- Anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid: Physiologic Uptake Patterns, Incidental Findings, and Variants That May Simulate Disease
- Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics
- 11C-Acetate PET/CT Before Radical Prostatectomy: Nodal Staging and Treatment Failure Prediction
- Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
- 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
- Putative Transport Mechanism and Intracellular Fate of Trans-1-Amino-3-18F-Fluorocyclobutanecarboxylic Acid in Human Prostate Cancer
- In Vivo Imaging of Intraprostatic-Specific Gene Transcription by PET
- New Agents and Techniques for Imaging Prostate Cancer
- Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
- Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer
- Humanized Radioiodinated Minibody For Imaging of Prostate Stem Cell Antigen-Expressing Tumors
- Tumor Cell Metabolism Imaging
- The Impact of Urinary Excretion of 18F-Labeled Choline Analogs
- Biodistribution and Radiation Dosimetry of the Synthetic Nonmetabolized Amino Acid Analogue Anti-18F-FACBC in Humans
- A Preliminary Study of Anti-1-Amino-3-18F-Fluorocyclobutyl-1-Carboxylic Acid for the Detection of Prostate Cancer